Literature DB >> 23960093

Development of healthcare quality indicators for rheumatoid arthritis in Europe: the eumusc.net project.

Ingemar F Petersson1, Britta Strömbeck, Lene Andersen, Marco Cimmino, Rolf Greiff, Estibaliz Loza, Carlo Sciré, Tanja Stamm, Michaela Stoffer, Till Uhlig, Anthony D Woolf, Theodora P M Vliet Vlieland.   

Abstract

BACKGROUND: Eumusc.net (http://www.eumusc.net) is a European project supported by the EU and European League Against Rheumatism to improve musculoskeletal care in Europe.
OBJECTIVE: To develop patient-centred healthcare quality indicators (HCQIs) for healthcare provision for rheumatoid arthritis (RA) patients.
METHODS: Based on a systematic literature search, existing HCQIs for RA were identified and their contents analysed and categorised referring to a list of 16 standards of care developed within the eumusc.net. An international expert panel comprising 14 healthcare providers and two patient representatives added topics and during repeated Delphi processes by email ranked the topics and rephrased suggested HCQIs with the preliminary set being established during a second expert group meeting. After an audit process by rheumatology units (including academic centres) in six countries (The Netherlands, Norway, Romania, Italy, Austria and Sweden), a final version of the HCQIs was established.
RESULTS: 56 possible topics for HCQIs were processed resulting in a final set of HCQIs for RA (n=14) including two for structure (patient information and calculation of composite scores), 11 for process (eg, access to care, assessments, and pharmacological and non-pharmacological treatments) and one for outcome (effect of treatment on disease activity). They included definitions to be used in clinical practice and also by patients. Further, the numerators and the denominators for each HCQI were defined.
CONCLUSIONS: A set of 14 patient-centred HCQIs for RA was developed to be used in quality improvement and bench marking in countries across Europe.

Entities:  

Keywords:  Multidisciplinary team-care; Patient perspective; Quality Indicators; Rheumatoid Arthritis

Mesh:

Substances:

Year:  2013        PMID: 23960093     DOI: 10.1136/annrheumdis-2013-203765

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  The burden of disease in rheumatoid arthritis.

Authors:  Till Uhlig; Rikke H Moe; Tore K Kvien
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

2.  Overcoming challenges in order to improve the management of rheumatic and musculoskeletal diseases across the globe.

Authors:  Anthony D Woolf; Sherine Gabriel
Journal:  Clin Rheumatol       Date:  2015-02-21       Impact factor: 2.980

3.  [International quality indicators in rheumatology. Suggestions for rheumatoid arthritis].

Authors:  J Braun; F Bessler; H-J Lakomek; M Rudwaleit
Journal:  Z Rheumatol       Date:  2016-04       Impact factor: 1.372

Review 4.  Challenges and Opportunities in Using Patient-reported Outcomes in Quality Measurement in Rheumatology.

Authors:  Elizabeth R Wahl; Jinoos Yazdany
Journal:  Rheum Dis Clin North Am       Date:  2016-03-16       Impact factor: 2.670

5.  [Standards of care for people with rheumatoid arthritis in Europe : Translation and comments of the eumusc.net recommendations supported by EULAR performed by a national task force of the professional organisations DGRh and VRA supported by "Deutsche Rheumaliga"].

Authors:  J Braun; A Krause; M Aringer; G Burmester; F Bessler; J-M Engel; U Faubel; R Fischer-Betz; E Genth; E Gromnica-Ihle; B Hellmich; I Kötter; K Krüger; J Lakomek; H-M Lorenz; B Manger; E Märker-Hermann; K Minden; U Müller-Ladner; J Rautenstrauch; S Rehart; G Riemekasten; M Rudwaleit; W Rüther; G Schett; F Schuch; H Schulze-Koops; C Specker; S Wassenberg; D Wiek; A Zink; M Schneider
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

Review 6.  Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches.

Authors:  Ann M Chodara; Aimée Wattiaux; Christie M Bartels
Journal:  Curr Rheumatol Rep       Date:  2017-04       Impact factor: 4.592

Review 7.  Quality improvement in pediatric inflammatory bowel disease: moving forward to improve outcomes.

Authors:  Pauline Quach; Geoffrey C Nguyen; Eric I Benchimol
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

8.  [Cornerstones of quality assurance in medicine in Germany. Important impulse for the situation in treatment of rheumatism].

Authors:  J Braun; M Schneider; H-J Lakomek
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

9.  Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain.

Authors:  Jordi Gratacós; Jesús Luelmo; Jesús Rodríguez; Jaume Notario; Teresa Navío Marco; Pablo de la Cueva; Manel Pujol Busquets; Mercè García Font; Beatriz Joven; Raquel Rivera; Jose Luis Alvarez Vega; Antonio Javier Chaves Álvarez; Ricardo Sánchez Parera; Jose Carlos Ruiz Carrascosa; Fernando José Rodríguez Martínez; José Pardo Sánchez; Carlos Feced Olmos; Conrad Pujol; Eva Galindez; Silvia Pérez Barrio; Ana Urruticoechea Arana; Mercedes Hergueta; Pablo Coto; Rubén Queiro
Journal:  Rheumatol Int       Date:  2018-02-07       Impact factor: 2.631

10.  REAL-PANLAR Project for the Implementation and Accreditation of Centers of Excellence in Rheumatoid Arthritis Throughout Latin America: A Consensus Position Paper From REAL-PANLAR Group on Improvement of Rheumatoid Arthritis Care in Latin America Establishing Centers of Excellence.

Authors:  Pedro Santos-Moreno; Claudio Galarza-Maldonado; Carlo V Caballero-Uribe; Mario H Cardiel; Loreto Massardo; Enrique R Soriano; José Aguilar Olano; José F Díaz Coto; Gabriel R Durán Pozo; Inês Guimarães da Silveira; Vianna J Khoury de Castrejón; Leticia Lino Pérez; Carlos A Méndez Justo; Rubén A Montufar Guardado; Rafael Muños; Sergio Murillo Elvir; Ernesto R Paredes Domínguez; Bernardo Pons-Estel; Carlos R Ríos Acosta; Sayonara Sandino; Carlos E Toro Gutiérrez; Sol María Villegas de Morales; Carlos Pineda
Journal:  J Clin Rheumatol       Date:  2015-06       Impact factor: 3.517

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.